$HIMS Eyes Multi-Billion-Dollar Peptide Boom as 19 Key Compounds Gain Traction

Travis Hoium
03-03 16:19

Peptides could be a new multi-billion-dollar market for companies like Hims & Hers $HIMS.

What are these peptides, and what do they do?

Here's what you need to know about all 19 peptides in question today, 14 of which may soon be legal to compound (according to RFK) 👇

1. BPC-157

Note: These infographics are made by Gemini and are for informational purposes only.

2. Thymosin Alpha-1 (Ta1)

3. Thymosin Beta-4 Fragment (TB-500)

4. AOD-9604

5. CJC-1295

6. Ipamorelin Acetate

7. Selank Acetate (TP-7)

8. Semax

9. GHK-Cu (Copper Peptide)

10. GHRP-2

11. GHRP-6

12. Epitalon

13. KPV

14. Kisspeptin-10

15. Melanotan II

16. MOTS-c

17. PEG-MGF (Pegylated Mechano Growth Factor)

18. Emideltide (DSIP - Delta Sleep-Inducing Peptide)

19. Cathelicidin LL-37

For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.

🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now

Find out more here.

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.

Click to access the activity

Other helpful links:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment